"Mr. Wei, please answer me, is this data true or false?"
These words were like thunder exploding in everyone's ears.
Everyone looked at Dr. Schmitz in shock, stunned for a moment.
He actually publicly questioned the authenticity of the clinical trial report at the press conference. This is a provocation.
Good guy, you can't refute the other party's efficacy, so you just take the heat and suspect the other party of fraud.
Are you going to do whatever it takes to break up the domestic anti-cancer drug market?
Representatives of domestic pharmaceutical companies were all ashamed and annoyed. Originally, they thought the new anti-cancer drugs were so effective that they couldn't believe it.
But Dr. Schmitz's arrogant questioning, his contempt and suspicion of domestic pharmaceutical companies, seemed like a huge slap in the face of all of them, instantly arousing their hatred and hatred.
Even Mr. Wu from Xinmei looked ugly at the moment and was extremely angry. He had seen this kind of arrogance and prejudice many times when dealing with foreign giants. Seeing Sanqing being questioned at this moment, I felt a little bit the same way, as if every questioning was torturing my soul.
He clenched his fists and said to himself: "Little bastard, don't lie. If your lies are exposed by foreigners and embarrass all domestic pharmaceutical companies, I will never let you go."
The faces of the media were also very ugly at this time. At first, they were ecstatic inside, thinking they had caught a breaking news.
But they quickly reacted and were angered by Schmitz's doubts.
Why, Chinese pharmaceutical companies can’t produce effective anti-cancer drugs, right?
Why do you suspect that Sanqing data is fake?
Other international pharmaceutical giants all showed gloating smiles.
Although they were all shocked by Schmitz's direct questioning, it did speak to their innermost thoughts.
Originally, they came here with doubts, but after seeing the clinical data, they simply didn't believe it.
So many pharmaceutical companies around the world invest tens of billions in research and development every year, but in the end, such a little-known Chinese pharmaceutical company developed this miracle drug.
It's unbelievable, this is absolutely fake.
They thought so in their hearts, but after all, there is no direct competition yet, so there is no need to break up like Merck.
So the representative of Roche Pharmaceuticals nodded in agreement.
Everyone else had a curious expression on their faces.
Therefore, everyone looked at Wei Kang with great anticipation to see how he would respond to this question.
Wei Kang naturally has no stage fright at all.
He sneered and asked sharply.
"Dr. Schmitz, I would like to ask, is Merck's drug research and development capabilities the best in the world? Can it represent the highest strength of the global pharmaceutical industry?"
"As far as I know, the world's number one pharmaceutical company is not Merck. Moreover, your strength in anti-cancer drugs is not very strong. Only Keytruda, a leading product, is strong in anti-cancer targeted drugs and immunotherapy." In terms of drug research and development, it is really lackluster.”
Wei Kang's words made Dr. Schmitz a little angry.
"Are you doubting my authority?"
"Young man, it is true that Merck is not the world's number one pharmaceutical company, and it is true that we only have Keytruda, a leading anti-cancer product. But we have been working tirelessly to develop anti-cancer drugs."
"We have been working hard in the field of anti-cancer drugs for decades, and the amount of R&D funds we invest every year is beyond your imagination. Last year, Merck's oncology business revenue was US$15.8 billion, but our R&D investment last year was also the highest among all pharmaceutical giants. Reached $13.5 billion."
"I think the tens of billions of R&D investments every year can explain something."
"The amount of money we have invested cannot match that of all the pharmaceutical companies in your country combined, and even far exceeds the market value of many of your pharmaceutical companies."
"Mr. Wei, I would like to ask, how much money does your company invest in research and development every year?"
Wei Kang nodded and said, "What you said makes sense, so you mean whoever spends more money to develop drugs will be successful? Whoever spends less money will definitely not be successful?"
"I remember news reports that Merck spends billions of dollars every year to buy new drug formulas from other laboratories, and even acquires many other small pharmaceutical companies. Is this true?"
"Since you are so rich and have invested tens of billions of dollars, why haven't you developed a second Keytruda or other targeted drugs?"
"You have so much money, why haven't you developed new drugs that small pharmaceutical companies can develop?"
Dr. Schmitz was suddenly speechless. He couldn't find the words to argue.
After all, in this industry, we only look at results, not words.
No matter how much you talk about it, how much money you invest, but if there are no results, it just won’t work.
This young man is really sharp-tongued and difficult to deal with!
However, he will not back down, he must completely force the opponent into a blind corner and make it impossible for him to stand up.
After all, Merck's oncology business revenue accounts for 40% of its pharmaceutical business revenue, and more than 95% of its revenue comes from Keytruda. It can be said that Merck's oncology business revenue is tied to Keytruda, which is extremely risky. If a broad-spectrum anti-tumor drug with miraculous efficacy emerges and completely replaces Keytruda, it will be a nightmare for the company.
In China's anti-cancer drug market, Merck's pharmaceutical business revenue in China reached US$3.534 billion, a year-on-year increase of 13%, making it Merck's best-performing market in the world.
The global oncology market has reached US$150 billion and has maintained a rapid growth of 15% in the past five years. It is expected to exceed the US$200 billion mark in the next few years. Among them, China's market accounts for less than 10%, and its share of the overall drug market is also less than 10%. It is relatively low and is still in the early stages of development, with broad room for future development.
Every pharmaceutical giant will not give up on the huge potential of the Chinese market.
So Dr. Schmitz came up with his trump card.
"Mr. Wei, clinical trial data can be faked. How do you prove that these data are true?"
Wei Kang smiled slightly, haha, I have been waiting for your words.
Do you think I would come to this press conference unprepared to face you arrogant foreign devils?
He said flatly: "This clinical data report is absolutely true, I can guarantee it."
"And I have evidence here."
He turned on the computer and played new information on the screen.
"These are the cases of some patients at Kunming First People's Hospital. You can clearly see the comparison before and after the patients took our new drugs. Here are the blood test reports, here are the CT and color ultrasound, and there are also some patients' surgery and treatment information. and before and after photos of the patient.”
"We have obtained the consent of a hundred patients in total, and they are willing to share their cases as evidence so that everyone can see how miraculous the effect of this drug is."
"Each of you can come to my place to see the case data of these 100 patients, but for the sake of patient privacy, you can only read it here and cannot take it out."
"For any drug, all paper data are pale. Only the patient's efficacy is the most intuitive and real evidence. Only the patient's recovery can prove the success of this drug."
"Then, please take a good look at how successful our new anti-cancer drug is!"
"If you still hold prejudices and are unwilling to believe the real data and cases I have provided, then I can only wait until this drug is launched and then slap you in the face."
"I'll wait and see!"
At this time, a female doctor in a white coat suddenly stood up from the audience and said loudly: "I am an oncologist at Kunming First People's Hospital. I can guarantee the authenticity of these cases."
Immediately, several doctors in white coats stood up next to her. They were all her colleagues, both young and old. They all nodded in unison, solemnly declared their identities and made guarantees.
Dr. Schmitz's face turned red, he hesitated for a long time, and then said: "Then the side effects in your report are so small, it is absolutely impossible!"
Wei Kang snorted coldly, looked at him and said, "Oh, your Keytruda has serious side effects, so you think the anti-cancer drug we developed should also have serious side effects?"
He suddenly laughed: "Let me think about the side effects of Keytruda?"
"Well, it seems that there are indeed many side effects," Wei Kang chuckled and recited a passage he had prepared in one breath.
“Main adverse reactions of Keytruda include edema, dizziness, diarrhea, nausea, hypoesthesia, dyspnea, myalgia, cognitive impairment, cough, vomiting, pyrexia, joint pain, and visual abnormalities.”
“The most serious adverse reactions include congestive heart failure, central nervous system reactions (cognitive impairment, anxiety, depression and even suicidal thoughts, dizziness or loss of stability, insomnia or excessive sleep), fractures, liver toxicity, and hyperuricemia , QT interval prolongation and visual abnormalities.”
After reciting it, he sneered and said, "Does this medicine of yours save people or kill people?"
"Dr. Schmitz, just because you can't do it, doesn't mean we can't do it."
"After so many years of development and revitalization, our country's pharmaceutical industry has become very developed. I dare not say it is better than the top international pharmaceutical companies, but in some aspects it has reached the international leading level."
"On this point, Mr. Wu of Xinmei Pharmaceutical Group should have a say."
"As far as I know, Xinmei Group has recently developed an anti-cancer injection for lymphoma. It can be cured in two months and has no serious side effects. Mr. Wu, am I right?"
Mr. Wu was sitting below and was listening intently when he was suddenly called upon by Wei Kang and couldn't help but be startled.
When he reacted, he was very proud in his heart. He raised his chest and raised his head and said, "Yes, our Xinmei is also very strong in the research and development of anti-cancer targeted drugs. At least the targeted drugs are no worse than Merck. Haha. "
He looked at Pfizer's Andre and said with a smile: "Moreover, Xinmei has recently cooperated with Pfizer to create a matrix of anti-cancer targeted drugs. Mr. Andre, am I right?"
Andre hesitated for a moment and nodded slightly.
Dr. Schmitz turned pale and sat down without saying a word.
The media reporters were stunned. Why were the people from these pharmaceutical companies silent?
Could it be that the clinical trial report is true and what Wei Kang said has been confirmed?
They immediately became excited.
Wow, big news. Sanqing Pharmaceutical faced provocation from international pharmaceutical giants at the new drug launch conference and was slapped on the spot!
Faced with the questioning of the global authority on oncology, General Health and Welfare made the other party speechless with a heated exchange of words!
At the same time, he resolutely presented evidence, defended his reputation, and boosted the reputation of my country's pharmaceutical industry!
If this was reported, there would be another shocking headline and patriotic news.
Sanqing’s new anti-cancer drug is really surprising. This new anti-cancer drug is 100% effective and has zero side effects.
It will definitely replace the anti-cancer drugs of other pharmaceutical companies and become the most popular and legendary miracle drug in the next few decades.
